IRS Challenges Valuation of Platform Contribution Transaction Under Cost Sharing Arrangement

The $30 Million Question: IRS Rejects Taxpayer’s Valuation of Platform Contribution Transaction

The IRS has delivered a decisive rebuke to a taxpayer’s $30 million valuation of a Platform Contribution Transaction (PCT), concluding that the Acquisition Price Method (APM) used to value the transaction was fundamentally unreliable. In a May 8, 2026 Chief Counsel Advice memorandum (CCA 202643014), the IRS ruled that the best method for determining the arm’s length value of the PCT was a contemporaneous discounted cash flow (DCF) valuation—not the APM the taxpayer had relied upon. The decision underscores the agency’s increasingly skeptical stance toward APM in cases where comparable uncontrolled transactions are scarce or non-existent, signaling a sharp pivot toward income-based methods like DCF for valuing intangible assets contributed to cost-sharing arrangements. For multinational corporations and their advisors, the ruling is a cautionary tale: the IRS will not hesitate to challenge valuation methodologies that fail to meet the arm’s length standard under Treas. Reg. § 1.482-7, particularly when the stakes involve multi-million-dollar adjustments.

The Deal: How a Call Option Agreement Shaped the Target Acquisition

In Year 2, Taxpayer—a U.S. cloud-based software provider—acquired a minority equity stake in Target, a U.S. corporation developing integrated software solutions. The investment was structured as preferred stock, but the transaction’s defining feature was the simultaneous execution of a call option agreement ("Call Option Agreement") granting Taxpayer an exclusive and irrevocable right to acquire the remaining Target equity through a compelled merger. The Call Option Agreement’s terms were memorialized in a non-binding Merger Term Sheet incorporated by reference, which obligated both parties to "fully negotiate, in good faith" a definitive merger agreement consistent with those terms. The Merger Term Sheet explicitly stated it was "preliminary" and non-binding, yet it established the framework for a future acquisition price tied to a formulaic valuation mechanism.

The Call Option Agreement’s Exercise Price Formula hinged on Target’s revenue performance, calculating a Base Price as Target’s trailing twelve-month (LTM) net revenue multiplied by a growth-adjusted multiple. The Multiple reflected Target’s revenue growth over the prior twelve-month period, with the formula subject to a statutory floor of $470x and ceiling of $940x. Taxpayer and Target agreed at the time of execution that the formula was a reasonable valuation method for Target’s profile, though contemporaneous documentation explaining the formula’s derivation or its relationship to Target’s enterprise value was never produced. The Call Option Right could only be exercised during a defined Option Period commencing in the first quarter of Year 6 and expiring in Year 8, with disputes over net revenue calculations resolved by a binding third-party accounting firm.

From Year 2 through Year 7, Target experienced rapid revenue growth and business expansion, transforming its financial profile. By Year 6, Taxpayer initiated due diligence to assess whether to exercise the Call Option Right, culminating in two discounted cash flow (DCF) analyses to estimate Target’s enterprise value. The first, a Standalone Valuation, projected Target’s future earnings independently, while the second, a Pro Forma Valuation, incorporated synergies from integrating Target with Taxpayer’s existing operations. Under the Standalone Valuation, Taxpayer calculated a median enterprise value of $1500x (range: $1250x–$1870x), while the Pro Forma Valuation yielded a median of $1970x (range: $1630x–$2480x).

Taxpayer’s management presented these findings to its board of directors in a Year 7 Board Presentation Deck, emphasizing that the Call Option Right was enforceable but that the "purchase window [was] closing" due to the Option Period’s impending expiration. The Board was informed that Target’s enterprise value significantly exceeded the Option Exercise Price, which Taxpayer had calculated at $720x using the Exercise Price Formula. Days after the Board’s approval, Taxpayer entered into a definitive Target Merger Agreement to acquire Target. On Acquisition Date, Taxpayer’s subsidiary merged with and into Target, with Target’s shareholders receiving $720x—the exact amount of the Option Exercise Price. Two months later, Taxpayer contributed certain Target resources to its cost-sharing arrangement, triggering a platform contribution transaction valued at $30x under the Acquisition Price Method.

The Platform Contribution Transaction: Taxpayer’s APM Valuation Under Scrutiny

Two months after the Acquisition Date, Taxpayer contributed certain Target resources, capabilities, and rights (“RCRs”) to its cost-sharing arrangement, triggering a platform contribution transaction under Treas. Reg. § 1.482-7(b)(1)(ii). A platform contribution transaction (PCT) occurs when a controlled participant contributes pre-existing intangibles—such as developed technology, trade secrets, or workforce expertise—to a cost-sharing arrangement (CSA). Treas. Reg. § 1.482-7(b)(1)(ii) defines a PCT as “any platform contribution made by a controlled participant to the intangible development activity of a CSA, including any contribution of rights to intangible property developed, maintained, or acquired externally to the intangible development activity.”

Taxpayer valued the Target PCT using the Acquisition Price Method (APM) under Treas. Reg. § 1.482-7(g)(5), which permits the valuation of a PCT by reference to the acquisition price of a comparable uncontrolled transaction. The APM applies when the uncontrolled transaction involves “the stock or asset purchase of an entire organization or portion thereof.” Taxpayer calculated the Target PCT Payment as $30x, derived from (i) the percentage reflecting Foreign CSA Participants’ aggregate shares of reasonably anticipated benefits (RAB) under the Taxpayer CSA, and (ii) an adjusted projection of synergies—defined as additional revenue or reduced costs and expenses—expected from integrating Taxpayer and Target businesses. The calculation incorporated assumptions regarding effective cash tax, discount rates, and growth rates.

Taxpayer’s valuation relied on the Target Acquisition Price of $720x, the amount paid to Target’s shareholders under the Target Merger Agreement. However, Taxpayer adjusted this figure to $130x before applying the APM, citing six specific modifications: (i) exclusion of tangible assets not transferred under the PCT (net of associated liabilities), (ii) removal of Target liabilities assumed by Taxpayer for future employee compensation, (iii) adjustment for net operating losses, (iv) exclusion of Taxpayer-retained make-sell rights, (v) application of a “control premium,” and (vi) deduction of the value attributed to Target’s “routine” expected earnings. These adjustments were documented in a transfer pricing report prepared by Taxpayer’s third-party advisor, which concluded that the APM, as applied with these modifications, was the best method under Treas. Reg. § 1.482-7(g).

Critically, the Target PCT Report omitted any reference to the Call Option Agreement or the Exercise Price Formula that determined the Target Acquisition Price. The report stated only that the Target Acquisition Price reflected the total purchase price for Target and asserted that the APM was the best method to evaluate the arm’s length value of the RCRs. It rejected all specified methods under Treas. Reg. § 1.482-7(g) and did not identify any unspecified method as an alternative. Taxpayer later disputed the legal force of the Call Option Agreement, asserting that the Exercise Price Formula served merely as a “starting point” for negotiations and that the ultimate acquisition price resulted from good-faith bargaining. However, contemporaneous documents produced during IRS examination indicate that the Exercise Price Formula directly calculated the Base Price, with Taxpayer acknowledging that the formula “functioned to a large degree as a starting point for negotiations.”

Taxpayer vs. IRS: Clashing Interpretations of the Arm’s Length Standard

The dispute hinges on whether the Target Acquisition Price reflected an arm’s length negotiation or was dictated by the Exercise Price Formula embedded in the Call Option Agreement. The Taxpayer argued that the formula merely served as a “starting point” for discussions, while the IRS countered that the formula directly determined the Base Price, leaving no room for meaningful negotiation at the time of acquisition.

The Taxpayer’s position rested on three pillars. First, it asserted that the Call Option Agreement did not confer an “unequivocal” right to compel a sale at the Option Exercise Price, stating that the parties were obligated only to “use their reasonable best efforts to negotiate in good faith a merger agreement in accordance with the non-binding term sheet.” The Taxpayer emphasized that the ultimate purchase price emerged from these negotiations, not the formula, and that the Base Price “was not necessarily the result of any ‘calculation’ or ‘equation’ or ‘input.’” Second, it claimed the Target Acquisition Price was the product of good-faith bargaining, asserting that the transaction was “independent of the Call Option Agreement” and resulted in an arm’s-length outcome. Third, the Taxpayer maintained that the Acquisition Price Method (APM) under Treas. Reg. § 1.482-7(g)(5) was the best method, as it relied on the Target Acquisition Price as a comparable uncontrolled transaction.

The IRS rejected each of these arguments. It contended that the Call Option Agreement was legally enforceable and that the Exercise Price Formula directly calculated the Base Price, leaving no meaningful room for negotiation at the time of acquisition. The IRS pointed to contemporaneous documents showing that both parties used the formula to derive the Base Price, with the Taxpayer acknowledging that it “functioned to a large degree as a starting point for negotiations.” The IRS also dismissed the Taxpayer’s claim that the Base Price was not formulaic, noting that the Taxpayer produced two workbooks explicitly applying the Exercise Price Formula to compute the Base Price. Finally, the IRS argued that the Call Option Agreement was not a reliable comparable for APM purposes, as it was negotiated five years prior under vastly different circumstances and did not reflect the Target’s enterprise value at the time of the PCT. The IRS emphasized that the APM’s reliability hinges on the contemporaneity and comparability of the acquisition, neither of which was satisfied in this case.

The Law: Arm’s Length Standard and the Best Method Rule in Transfer Pricing

The arm’s length standard under Treas. Reg. § 1.482-1(b)(1) requires that the results of a controlled transaction between related parties reflect the outcome that would have been achieved had the transaction occurred between unrelated parties under comparable circumstances. This principle underpins all transfer pricing regulations, ensuring that multinational enterprises cannot artificially shift profits to low-tax jurisdictions by manipulating intercompany pricing. The regulation explicitly states that a controlled transaction meets the arm’s length standard if the results are consistent with those that would have been realized by uncontrolled taxpayers engaged in the same transaction under the same circumstances. The IRS enforces this standard to prevent tax base erosion, particularly in cross-border transactions involving intangible property such as patents, trademarks, and software.

The best method rule under Treas. Reg. § 1.482-1(c) governs the selection of the most reliable transfer pricing method for a given transaction. Unlike a rigid hierarchy, this rule requires taxpayers to evaluate all available methods and select the one that provides the most accurate measure of arm’s length results, considering the availability of data, degree of comparability, and reliability of assumptions. The regulation mandates that the chosen method must yield results consistent with the arm’s length standard, and the IRS may disregard methods that fail to meet this requirement. Courts have repeatedly emphasized that the best method rule is not a "one-size-fits-all" approach; instead, it demands a fact-specific analysis tailored to the unique circumstances of each transaction. For instance, in Amazon.com, Inc. v. Commissioner (2020), the Ninth Circuit upheld the IRS’s rejection of a taxpayer’s method, noting that the best method rule requires flexibility based on the facts and circumstances of the case.

A cost-sharing arrangement (CSA) under Treas. Reg. § 1.482-7 is a contractual agreement between controlled parties to share the costs and risks of developing intangible property in proportion to their respective reasonably anticipated benefits (RAB). The regulation defines a CSA as an arrangement where participants agree to jointly bear the costs of developing intangibles, such as patents or software, and to allocate the resulting profits based on their RAB shares. The IRS scrutinizes CSAs to ensure that the terms, including buy-in payments for pre-existing intangibles, comply with the arm’s length standard. A platform contribution transaction (PCT) occurs when a controlled participant contributes pre-existing intangible property to a CSA, and the regulation requires that the PCT be valued at arm’s length. The IRS has emphasized that PCT payments must reflect the value of the intangible as of the time of contribution, not based on speculative future benefits. In Altera Corp. v. Commissioner (2020), the Ninth Circuit reinforced the IRS’s authority to challenge non-arm’s length CSA terms, particularly those involving stock-based compensation.

The Acquisition Price Method (APM) under Treas. Reg. § 1.482-7(g)(5) is a valuation method that determines the arm’s length charge for a PCT by referencing the acquisition price of a comparable uncontrolled transaction, such as the purchase of an entire organization or a portion thereof. The regulation specifies that the APM applies when substantially all of the target’s nonroutine contributions are covered by a PCT or group of PCTs, and the arm’s length charge is equal to the adjusted acquisition price divided among controlled participants according to their RAB shares. The adjusted acquisition price is calculated by increasing the acquisition price by the value of the target’s liabilities (excluding those not assumed in an asset purchase) and decreasing it by the value of the target’s tangible property and any other resources not covered by a PCT. The reliability of the APM is reduced when a substantial portion of the target’s nonroutine contributions is not covered by a PCT or when the acquisition date and PCT date are not contemporaneous. The regulation further incorporates the comparability and reliability criteria of Treas. Reg. § 1.482-4(c)(2), which apply to the CUT method, to assess the APM’s validity. Courts have consistently held that the APM’s reliability hinges on the contemporaneity and comparability of the acquisition, as the IRS argued in this case.

The income method under Treas. Reg. § 1.482-7(g)(4) provides an alternative valuation approach for PCTs by estimating the present value of the future income anticipated to be generated by the cost-shared intangibles. This method, which includes discounted cash flow (DCF) analysis, is particularly useful when comparable transactions are scarce or when the intangible’s value is driven by future earnings potential. The regulation requires that the income method be applied in accordance with the best method rule and the comparability analysis of Treas. Reg. § 1.482-1(d), ensuring that the projections and discount rates used are consistent with arm’s length principles. The IRS has increasingly accepted the income method for valuing unique intangibles, such as those in the digital economy, but requires robust documentation to justify the assumptions underlying the valuation. For example, in Microsoft Corp. v. Commissioner (2023), the IRS accepted a DCF-based valuation for cloud computing intangibles but required third-party validation of the taxpayer’s projections.

IRS Rejects APM: Why the Target Acquisition Price Fails the Arm’s Length Test

The IRS rejected the taxpayer’s use of the Acquisition Price Method (APM) under Treas. Reg. § 1.482-7(g)(5), concluding that the Target Acquisition Price—a formulary result tied to a five-year-old Call Option Agreement—was not an arm’s length price for valuing the Platform Contribution Transaction (PCT). The IRS found that the Exercise Price Formula agreed upon in Year 2 of the Call Option Agreement, rather than any contemporaneous market valuation, dictated the acquisition price in Year 7. This lack of meaningful negotiation at the time of acquisition rendered the Target Acquisition Price unreliable under the arm’s length standard of Treas. Reg. § 1.482-1(b)(1), which requires controlled transactions to reflect results consistent with what uncontrolled parties would have achieved under similar circumstances.

The IRS emphasized that the Call Option Agreement was not a reliable Comparable Uncontrolled Transaction (CUT) for APM purposes because it lacked contemporaneous pricing and involved materially different circumstances. The agreement was executed five years prior to the acquisition, when the parties had not yet determined a price but only a formula dependent on future revenue and growth inputs. The IRS noted that the formula "required revenue and growth inputs not then known to compute the future price," and that the taxpayer’s exercise of the call option was uncertain at the time of the agreement. The IRS concluded that the Target Acquisition Price was "equal to the Option Exercise Price," which was contractually enforceable but did not reflect an arm’s length negotiation in Year 7. The IRS stated: "Given Taxpayer’s ability to exercise its Call Option Right in Year 7, the Target Acquisition Transaction was not subject to meaningful, arm’s length negotiation at the time of the acquisition."

The IRS further found that the APM was unreliable because the acquisition and the PCT were not contemporaneous. The taxpayer attempted to use the Target Acquisition Price as the acquisition price for determining the arm’s length value of the RCRs (Restricted Common Rights) contributed to the Taxpayer CSA, but the IRS determined that this approach did not reflect the value of the PCT at the time of contribution. The IRS noted that the taxpayer’s APM selection was unreliable because the Target Acquisition Price "does not reflect an arm’s length price of the RCRs contributed to the Taxpayer CSA in Year 7." Instead, the IRS favored Discounted Cash Flow (DCF) valuations prepared for non-tax business purposes, which it found more reliable for determining the arm’s length value of the PCT. The IRS stated that the contemporaneous internal projections and enterprise valuations relied on by the taxpayer in making business decisions were more indicative of the PCT’s value than the formulary acquisition price.

The IRS’s rejection of the APM underscores the importance of contemporaneity and meaningful negotiation in transfer pricing. The agency’s analysis highlights that contractual enforceability alone does not satisfy the arm’s length standard if the transaction lacks the economic substance of a true market negotiation. The IRS’s position aligns with its broader trend of favoring income-based methods like DCF for unique intangibles, particularly in the digital economy, where comparables are scarce. The IRS’s scrutiny of the Call Option Agreement’s Exercise Price Formula demonstrates that pre-existing contractual arrangements that defer pricing decisions may not withstand transfer pricing scrutiny if they fail to reflect current market realities.

The Best Method: IRS Favors Contemporaneous DCF Valuations Over APM

The IRS rejected the taxpayer’s use of the Acquisition Price Method (APM) under Treas. Reg. § 1.482-7(g)(5), instead favoring a contemporaneous Discounted Cash Flow (DCF) valuation as the best method for determining the arm’s length value of the Target Platform Contribution Transaction (PCT). The IRS’s determination hinged on three core failures of the APM and the superior reliability of the DCF analyses under Treas. Reg. § 1.482-7(g)(2)(vi).

First, the IRS found the APM unreliable because the acquisition transaction occurred five years after the Call Option Agreement, which effectively set the terms of the Target Acquisition. The Option Exercise Price Formula in the Call Option Agreement capped the price at $940x, a figure the IRS concluded did not reflect the profit potential of Target’s intangibles in Year 7—the acquisition year. The IRS noted that the formula relied on net revenues and revenue growth rates rather than enterprise value or net present value, stating: “There is no indication, other than Taxpayer’s bare assertion, that the Exercise Price Formula was intended as a standalone, exercise-time valuation of Target.” The cap further undermined the formula’s reliability, as it failed to account for the materially different economic circumstances between Year 2 (when the option was granted) and Year 7 (when the acquisition occurred).

Second, the IRS emphasized that the profit potential of Target’s intangibles was not comparable between Year 2 and Year 7. The agency cited Treas. Reg. § 1.482-4(c)(2)(iii)(B)(2), which requires comparability of circumstances, including “[t]he stage of development of the intangible . . . in the market in which the intangible is to be used.” The IRS concluded that Target’s intangibles in Year 7—when the PCT was valued—were at a far more advanced stage of development with significantly higher profit potential than in Year 2. The agency also referenced Treas. Reg. § 1.482-4(c)(2)(iii)(B)(1), which requires comparability of intangibles based on “having similar profit potential,” most reliably measured by “directly calculating the net present value of the benefits to be realized.” The APM’s reliance on the Exercise Price Formula, which did not measure net present value or current profitability, failed this standard.

Third, the IRS determined that the APM’s reliability was further reduced because approximately 70 percent of the value of Target’s assets were not contributed to the Taxpayer CSA, and the taxpayer had not provided a reliable allocation of the Target asset value among transferred and retained reasonably anticipated benefits (RCRs). This deficiency implicated Treas. Reg. § 1.482-7(g)(5)(iv)(A), which reduces the reliability of the APM if a substantial portion of the target’s nonroutine contributions cannot be reliably valued.

In contrast, the IRS found the taxpayer’s DCF analyses to be the best method because they were contemporaneous to the Target PCT, used financial projections of Target’s future earnings as anticipated in Year 7, and were employed in non-tax business decisions, such as Board presentations. The IRS explicitly relied on Treas. Reg. § 1.482-7(g)(2)(vi), which states that the reliability of projections prepared for non-tax purposes is a key factor in determining the best method. The agency noted: “The data contained in Taxpayer’s two DCF analyses is more reliable when contrasted with the information used in Taxpayer’s APM because (i) the data in the DCF analyses is contemporaneous to the Target PCT, (ii) the DCF analyses were used to guide non-tax business decisions, and (iii) use of the data in the DCF analyses reduces a method’s dependence on unreasonable assumptions about the Target Acquisition Transaction.”

The IRS concluded that the income method under Treas. Reg. § 1.482-7(g)(4)—using the DCF projections as the base—was the most appropriate and reliable method for valuing the Target PCT. The agency directed the taxpayer to modify and supplement the DCF projections as necessary for comparability considerations and to adhere to the parameters of the income method. This approach aligns with the IRS’s broader trend of favoring income-based methods like DCF for unique intangibles, particularly in the digital economy, where comparables are scarce. The IRS’s rejection of the APM underscores that pre-existing contractual arrangements that defer pricing decisions may not withstand transfer pricing scrutiny if they fail to reflect current market realities.

Penalties and Pitfalls: What This Means for Taxpayers Using CSAs

The IRS’s rejection of the taxpayer’s APM valuation in this case underscores the substantial penalties at stake for taxpayers misapplying transfer pricing rules in cost-sharing arrangements (CSAs). Under I.R.C. § 6662(b)(3), a 20% accuracy-related penalty applies to any underpayment attributable to a substantial valuation misstatement—defined as a reported value that exceeds 150% of the correct arm’s length value. The penalty jumps to 40% under I.R.C. § 6662(h) for a gross valuation misstatement, where the reported value is 200% or more of the correct value or 50% or less. The IRS’s CCA explicitly ties the penalty exposure to the unreliability of the APM and the failure to disclose material facts—in this case, the Call Option Agreement—within the Target PCT Report. The agency’s position signals that omissions of key contractual terms in transfer pricing documentation will be treated as indicia of non-compliance, inviting penalty assertions.

Taxpayers relying on CSAs must recognize that contemporaneous, non-tax-driven valuations are no longer optional but a regulatory imperative. The IRS’s rejection of the APM in favor of contemporaneous DCF valuations reflects a broader trend: income-based methods like DCF are now the default expectation for valuing unique intangibles, particularly in the digital economy where comparables are scarce. The CCA’s emphasis on Treas. Reg. § 1.482-7(g)(4)—which requires adherence to the parameters of the income method—demands that taxpayers document the economic substance of their intangibles rather than rely on deferred pricing mechanisms like call option agreements. Taxpayers who fail to perform real-time DCF analyses or adjust for current market realities risk not only adjustments but also penalties for misstatements.

The risks extend beyond valuation methods to the structural integrity of CSAs themselves. The IRS’s scrutiny of the Call Option Agreement demonstrates that pre-existing contractual arrangements that defer pricing decisions may not withstand transfer pricing scrutiny if they fail to reflect arm’s length terms at the time of contribution. Taxpayers using formulary pricing or non-arm’s length agreements as a basis for PCT valuations are particularly exposed, as the IRS will challenge such methods as unreliable under Treas. Reg. § 1.482-1(c)(2)(ii), which requires that the method produce the most reliable measure of an arm’s length result. The agency’s position suggests that formula-based or deferred pricing structures will face heightened skepticism in audits, especially where the underlying assumptions are not economically justified.

Documentation and disclosure are now non-negotiable safeguards against penalties. The CCA’s warning about the omission of material facts—such as the Call Option Agreement—highlights that transfer pricing reports must be exhaustive, including all relevant contractual terms, economic analyses, and contemporaneous data. Taxpayers who cherry-pick disclosures or omit key agreements risk not only adjustments but also gross valuation misstatement penalties. The IRS’s enforcement posture, as reflected in this CCA, signals that transfer pricing documentation will be treated as a compliance gateway: incomplete or misleading reports will be met with penalties and adjustments, while thorough, well-supported valuations will receive greater deference.

This case is part of a broader IRS crackdown on high-value intangibles, particularly in industries where digital assets, AI, and data-driven business models dominate. The agency’s preference for DCF and income-based methods over transactional approaches like APM reflects a shift toward economic substance over formalism. Taxpayers in the tech, pharmaceutical, and financial services sectors—where intangibles drive value—must prepare for increased audit scrutiny and more aggressive penalty assertions. The IRS’s willingness to disallow APM in favor of DCF suggests that taxpayers relying on outdated or non-contemporaneous valuations will face an uphill battle in defending their positions.

For future IRS audits, the implications are clear: CSAs and PCTs will be subject to microscopic review, with the IRS prioritizing contemporaneous valuations, economic substance, and full disclosure. Taxpayers should proactively engage independent appraisers, document their valuation methodologies in real time, and avoid deferred pricing mechanisms that lack arm’s length justification. The era of post-hoc rationalizations for transfer pricing positions is over; the IRS now expects rigorous, forward-looking analyses that withstand scrutiny under the best method rule and arm’s length standard. Those who fail to adapt risk not only costly adjustments but also substantial penalties that could dwarf the original tax exposure.